Solid Biosciences (SLDB) Competitors $2.55 +0.03 (+1.19%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$2.55 0.00 (0.00%) As of 04/17/2025 06:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLDB vs. WVE, COLL, ELVN, DYN, GPCR, ETNB, CMRX, CDMO, RCUS, and VIRShould you be buying Solid Biosciences stock or one of its competitors? The main competitors of Solid Biosciences include Wave Life Sciences (WVE), Collegium Pharmaceutical (COLL), Enliven Therapeutics (ELVN), Dyne Therapeutics (DYN), Structure Therapeutics (GPCR), 89bio (ETNB), Chimerix (CMRX), Avid Bioservices (CDMO), Arcus Biosciences (RCUS), and Vir Biotechnology (VIR). These companies are all part of the "pharmaceutical products" industry. Solid Biosciences vs. Wave Life Sciences Collegium Pharmaceutical Enliven Therapeutics Dyne Therapeutics Structure Therapeutics 89bio Chimerix Avid Bioservices Arcus Biosciences Vir Biotechnology Wave Life Sciences (NASDAQ:WVE) and Solid Biosciences (NASDAQ:SLDB) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, community ranking, analyst recommendations, risk, dividends, media sentiment and valuation. Which has higher earnings and valuation, WVE or SLDB? Wave Life Sciences has higher revenue and earnings than Solid Biosciences. Wave Life Sciences is trading at a lower price-to-earnings ratio than Solid Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWave Life Sciences$108.30M8.35-$57.51M-$0.79-7.46Solid Biosciences$8.09M23.80-$96.01M-$3.04-0.82 Does the MarketBeat Community favor WVE or SLDB? Wave Life Sciences received 92 more outperform votes than Solid Biosciences when rated by MarketBeat users. However, 69.27% of users gave Solid Biosciences an outperform vote while only 67.84% of users gave Wave Life Sciences an outperform vote. CompanyUnderperformOutperformWave Life SciencesOutperform Votes36767.84% Underperform Votes17432.16% Solid BiosciencesOutperform Votes27569.27% Underperform Votes12230.73% Which has more volatility and risk, WVE or SLDB? Wave Life Sciences has a beta of -0.93, indicating that its share price is 193% less volatile than the S&P 500. Comparatively, Solid Biosciences has a beta of 2.07, indicating that its share price is 107% more volatile than the S&P 500. Do analysts rate WVE or SLDB? Wave Life Sciences presently has a consensus price target of $22.18, suggesting a potential upside of 276.28%. Solid Biosciences has a consensus price target of $15.67, suggesting a potential upside of 530.45%. Given Solid Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Solid Biosciences is more favorable than Wave Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 3.00Solid Biosciences 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 4 Strong Buy rating(s) 3.33 Is WVE or SLDB more profitable? Solid Biosciences has a net margin of 0.00% compared to Wave Life Sciences' net margin of -66.50%. Solid Biosciences' return on equity of -58.75% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Wave Life Sciences-66.50% -280.57% -52.90% Solid Biosciences N/A -58.75%-47.84% Does the media prefer WVE or SLDB? In the previous week, Wave Life Sciences had 17 more articles in the media than Solid Biosciences. MarketBeat recorded 18 mentions for Wave Life Sciences and 1 mentions for Solid Biosciences. Solid Biosciences' average media sentiment score of 1.36 beat Wave Life Sciences' score of 0.70 indicating that Solid Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wave Life Sciences 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Solid Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in WVE or SLDB? 89.7% of Wave Life Sciences shares are owned by institutional investors. Comparatively, 81.5% of Solid Biosciences shares are owned by institutional investors. 29.1% of Wave Life Sciences shares are owned by insiders. Comparatively, 13.6% of Solid Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummarySolid Biosciences beats Wave Life Sciences on 11 of the 19 factors compared between the two stocks. Get Solid Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SLDB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SLDB vs. The Competition Export to ExcelMetricSolid BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$194.12M$2.83B$5.30B$7.37BDividend YieldN/A1.90%5.11%4.31%P/E Ratio-0.8230.4521.6917.76Price / Sales23.80437.32377.9494.24Price / CashN/A168.6838.1534.64Price / Book0.403.436.413.98Net Income-$96.01M-$72.06M$3.20B$247.41M7 Day Performance-6.93%5.39%4.61%4.22%1 Month Performance-53.64%-18.17%-9.97%-7.89%1 Year Performance-75.13%-28.27%10.75%1.25% Solid Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SLDBSolid Biosciences3.3505 of 5 stars$2.55+1.2%$15.67+514.4%-74.5%$195.28M$8.09M-0.84100WVEWave Life Sciences4.1776 of 5 stars$5.80-3.8%$22.60+289.7%+23.6%$890.22M$108.30M-5.23240Short Interest ↑Analyst RevisionCOLLCollegium Pharmaceutical4.1748 of 5 stars$27.38-2.7%$43.60+59.2%-23.8%$879.77M$631.45M11.80210Gap DownELVNEnliven Therapeutics2.7822 of 5 stars$17.87-4.4%$38.75+116.8%-4.5%$875.70MN/A-9.4150Gap DownDYNDyne Therapeutics3.543 of 5 stars$7.49-9.5%$47.46+533.7%-67.1%$847.28MN/A-2.10100GPCRStructure Therapeutics2.5906 of 5 stars$14.31-5.4%$81.29+468.0%-41.3%$820.58MN/A-19.34136News CoveragePositive NewsGap UpETNB89bio2.599 of 5 stars$5.49-4.9%$27.56+401.9%-33.8%$801.45MN/A-1.8940Short Interest ↑High Trading VolumeCMRXChimerix2.7576 of 5 stars$8.52-0.1%$8.53+0.2%+844.7%$799.21M$212,000.00-9.0690Analyst ForecastNews CoverageCDMOAvid Bioservices0.7972 of 5 stars$12.50+0.1%$12.25-2.0%+86.2%$799.18M$139.91M-5.23320Upcoming EarningsHigh Trading VolumeRCUSArcus Biosciences2.3869 of 5 stars$7.28+5.9%$30.25+315.8%-46.8%$764.88M$258M-2.31500VIRVir Biotechnology2.4943 of 5 stars$5.52-1.1%$35.67+546.1%-33.3%$757.03M$63.71M-1.41580Analyst ForecastShort Interest ↑ Related Companies and Tools Related Companies Wave Life Sciences Competitors Collegium Pharmaceutical Competitors Enliven Therapeutics Competitors Dyne Therapeutics Competitors Structure Therapeutics Competitors 89bio Competitors Chimerix Competitors Avid Bioservices Competitors Arcus Biosciences Competitors Vir Biotechnology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SLDB) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solid Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Solid Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SLDB Stock Free SLDB Stock Alerts